Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
China Resources Double Crane: Wholly owned subsidiary's Sodium Acetate Ringer's Injection obtains drug registration certificate
China Resources Shuanghe announced that its wholly-owned subsidiary, Xi’an Jingxi Shuanghe Pharmaceutical Co., Ltd., recently received the “Drug Registration Certificate” for Sodium Acetate Ringers Injection issued by the National Medical Products Administration.
Sodium Acetate Ringers Injection is used to replenish extracellular fluid when circulating blood volume and interstitial fluid decrease, and to correct metabolic acidosis.
Jingxi Shuanghe initiated the generic drug development for this medication in November 2023, submitted the marketing approval application to the National Medical Products Administration on September 14, 2024, received the acceptance notice on September 26, 2024, and was approved for market launch by the NMPA on February 25, 2026.